Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Temsirolimus, Topotecan, and Bortezomib in Patients With Advanced Malignancy

NCT00770731 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00770731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00770731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Temsirolimus, Topotecan, and Bortezomib in Patients With Advanced Malignancy
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2008
Completion date
November 30, 2012
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer